000 02653cam a22004215a 4500
999 _c3722
_d3722
001 15675258
003 SUN
005 20180807121527.0
008 090128s2008 sz a b i000 0 eng
010 _a 2009388567
020 _a9789241547499
020 _a9241547499
035 _a(OCoLC)ocn300063303
040 _aHNC
_cSUNLIB
_dGUA
_dYDXCP
_dIXA
_dCOD
_dHL8
_dDLC
042 _alccopycat
050 0 0 _aRM301.9
_b.P73 2008
082 _a372.7/
_bWHO
245 0 2 _aA Practical handbook on the pharmacovigilance of antimalarial medicines.
260 _aGeneva, Switzerland :
_bWorld Health Organization,
_cc2008.
300 _aviii, 108 p. :
_bill. (some col.) ;
_c22 cm.
505 0 _aA. Introduction -- B. Passive or active pharmacovigilance? -- C. Spontaneous reporting -- D. Cohort event monitoring -- E. Data processing -- F. Special types of event -- G. Relationship/causality assessment -- H. Signal identification -- I. Strengthening the signal -- J. Identifying risk factors -- K. Analyses -- L. Differences between spontaneous reporting and cohort event monitoring -- M. Organization -- N. Communication -- Annex.
520 _aThis publication is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It provides information on spontaneous reporting of adverse drug reactions as a complement to other WHO publications. In addition, it provides details on how to conduct cohort event monitoring, which is a method of active safety surveillance collecting information on all adverse events occurring after treatment. It also details how to perform causality assessment and signal identification, applicable to both methods of surveillance.--Publisher's description.
530 _aAlso available online.
650 0 _aDrug monitoring.
_99144
650 0 _aAntimalarials
_xSide effects.
_99145
650 2 _aAdverse Drug Reaction Reporting Systems.
_99146
650 2 _aAntimalarials
_xadverse effects.
_99147
650 2 _aAntimalarials
_xstandards.
_99148
650 2 _aDrug Monitoring.
_99149
650 2 _aDrug Utilization Review
_xmethods.
_99150
650 2 _aPharmacoepidemiology
_xmethods.
_99151
650 2 _aProduct Surveillance, Postmarketing.
_99152
710 2 _aWorld Health Organization.
_94691
856 4 1 _uhttp://www.who.int/medicines/areas/quality_safety/safety_efficacy/handbook_antimalarialpharmvigilance.pdf
_zConnect to online resource
906 _a7
_bcbc
_ccopycat
_d3
_encip
_f20
_gy-gencatlg
942 _2ddc
_cBK